Vera Cavalli

Use of a octreotide as a therapeutic agent

USE OF BETA-MELANOTROPIN AS A THERAPEUTIC AGENT, EG FOR THE TREATMENT OF AIDS OR ALZHEIMER

USE OF GLP-1 AS A THERAPEUTIC AGENT

USE OF INSULIN C-PEPTIDE, ALONE OR IN COMBINATION WITH GLP-1, AS A THERAPEUTIC AGENT

USE OF A PEPTIDE AS A THERAPEUTIC AGENT

USE OF A PEPTIDE AS A THERAPEUTIC AGENT

USE OF SALUSIN BETA ALONE OR IN COMBINATION WITH OCTREOTIDE AS A THERAPEUTIC AGENT

USE OF A PEPTIDE AS A THERAPEUTIC AGENT

USE OF A PEPTIDE AS A THERAPEUTIC AGENT

USE OF A PEPTIDE AS A THERAPEUTIC AGENT

USE OF CNP-22, ALONE OR IN COMBINATION WITH PHYSALEMIN, AS A THERAPEUTIC AGENT

USE OF A PEPTIDE AS A THERAPEUTIC AGENT

USE OF FIBRONECTIN FRAGMENT (196-203 ) AS A THERAPEUTIC AGENT

USE OF THE PEPTIDE PRO-GLY-THR-CYS-GLU-ILE-CYS-ALA-TYR-ALA-ALA-CYS-THR-GLY-CYS AS A THERAPEUTIC AGENT

USE OF PEPTIDE AS A THERAPEUTIC AGENT

MINIGASTRIN AS A THERAPEUTIC AGENT

USE OF THE PEPTIDE ASN-ASP-ASP-CYS-GLU- LEU-CYS-VAL-ASN-VAL-ALA-CYS-THR-GLY-CYS-LEU ALONE OR IN COMBINATION WITH THE PEPTIDE THR-THR-SER-GLN-VAL- ARG-PRO-ARG AS A THERAPEUTIC AGENT

USE OF PEPTIDE LL-37 AS A THERAPEUTIC AGENT

THERAPEUTIC USES OF INTERMEDIN 47 AND 53 PEPTIDES

USE OF LEPTIN (22-56 ) AS A THERAPEUTIC AGENT

USE OF NEUROPEPTIDE SF, ALONE OR IN COMBINATION WITH GLP-2, AS A THERAPEUTIC AGENT

Use of the peptide RFMWMR as a therapeutic agent

USE OF GLUTEN EXORPHIN C : AS A THERAPEUTIC AGENT

USE OF OCTREOTIDE AS A THERAPEUTIC AGENT

GAMMA 1 MSH ALONE OR IN COMBINATION WITH PENTAGASTRIN AS A THERAPEUTIC AGENT

Use of Gonadorelin as a therapeutic agent

USE OF A PEPTIDE AS A THERAPEUTIC AGENT

USE OF CALCITONIN AS ANTI-ANGIOGENIC AGENT

USE OF TYR-W-MIF-1 AND UROCORTIN 2 AS THERAPEUTIC AGENTS

USE OF NEUROTROPHIC FACTOR FOR RETINAL CHOLINERGIC NEURONS (NFRCN) AND CHORIONIC GONADOTROPIN-BETA (109-145) AS THERAPEUTIC AGENTS

USE OF A PEPTIDE AS A THERAPEUTIC AGENT

USE OF MELANOTROPHIN-POTENTIATING FACTOR AS A THERAPEUTIC AGENT

THERAPEUTIC USE OF PEPTIDE YGLF AND COMBINATION WITH KVLPVPQ

USE OF PEPTIDE AS A THERAPEUTIC AGENT

USE OF RGDSPASSKP AND OPTIONALLY ANGIOTENSIN II AS THERAPEUTIC AGENTS IN THE TREATMENT OF EG S. PNEUMONIAE INFECTIONS

USE OF A FIBRINOGEN RECEPTOR ANTAGONIST AND/OR FOLLICULAR GONADOTROPIN RELEASING PEPTIDE AS A THERAPEUTIC AGENT IN THE TREATMENT OF STREPTOCOCCUS PNEUMONIA INFECTION

USE OF THE PEPTIDE HIS-SER-LEU-GLY-LYS-TRP-LEU-GLY-HIS-PRO-ASP-LYS-PHE ALONE OR IN COMBINATION WITH THE PEPTIDE PRO-GLY-THR-CYS-GLU-ILE-CYS-ALA-TYR-ALA-ALA-CYS-THR-GLY-CYS-OH AS A THERAPEUTIC AGENT

USE OF A PEPTIDE AS A THERAPEUTIC AGENT

USE OF A PEPTIDE AS A THERAPEUTIC AGENT

USE OF A PEPTIDE AS A THERAPEUTIC AGENT

USE OF SECRETIN AND OPTIONALLY URODILATIN AS THERAPEUTIC AGENTS

USE OF A RGD-PEPTIDE AND/OR PARATHYROID HORMONE (1-34) AS ANTI-HIV AGENT

Use of somatostatin-14 as a therapeutic agent

USE OF MELANOCYTE-STIMULATING HORMONE RELEASE-INHIBITING FACTOR AS A THERAPEUTIC AGENT IN THE TREATMENT OF PSEUDOMONAS AERUGINOSA INFECTION

SUBSTANCE P AND THYROTROPIN RELEASING HORMONE FOR THERAPEUTIC APPLICATIONS

USE OF MELANIN CONCENTRATING HORMONE AND MET-ENKEPHALIN AS THERAPEUTIC AGENTS

USE OF A PLATELET FIBRINOGEN RECEPTOR HEXAPEPTIDE ANTAGONIST AND ALPHA-ENDORPHIN AS THERAPEUTIC AGENTS

USE OF THE PEPTIDE THYMOSIN BETA 4 ALONE OR IN COMBINATION WITH CECROPIN A AS A THERAPEUTIC AGENT

Use of Peptide YY, alone or in combination with glucagon-like peptide, for use in medicine

BIG GASTRIN I AS A THERAPEUTIC AGENT

USE OF GLY-PRO-GLU-OH (GPE) AS A THERAPEUTIC AGENT

USE OF A DESLORELIN AND MASTOPARAN AS A THERAPEUTIC AGENT

USE OF A PEPTIDE AS A THERAPEUTIC AGENT

USE OF THE HUMAN PANCREATIC POLYPEPTIDE AS A THERAPEUTIC AGENT

USE OF A PEPTIDE AS A THERAPEUTIC AGENT

PROADRENOMEDULLIN ALONE OR IN COMBINATION WITH BIG GASTRIN I AS A THERAPEUTIC AGENT